R&D

Pipeline

Technology Target Product Indication Discovery Preclinical PhaseⅠ
PhaseⅡ
Antibody
(Tomaralimab)
TLR2 NM-101 PD arrow01      
NM-102 AD arrow02   amyloid solution  
NM-103 Neurodegenerative
disease
arrow03      
NM-104 Cancer arrow04      
NM-105 Immune disease arrow05      
BBB penetrating
Ab
BBB NM-301 Neurodegenerative
disease
arrow06   aptamer sciences  
Small molecule aSyn
aggregate
NM-401 PD arrow07   yungjin pharm  
NM-402 MSA arrow08   yungjin pharm  
NM-403 DLB arrow09   yungjin pharm  
Diagnostic aSyn
aggregate
NM-501 Diagnostics for CNS
disease
arrow010